Notably, a number of HLA molecules were downregulated in the Myc-induced RWPE cells, consistent with prior findings of loss of MHC class I presentation in prostate cancer (Blades et al., 1995; Cornel et al., 2020; Dhatchinamoorthy et al., 2021). Here, MYC is linked to prostate carcinoma.